Survivor Articles

Articles

  • Clinically relevant fatigue in recurrence-free prostate cancer survivors.

    Little is known about the prevalence and associations of clinically relevant fatigue (CRF) in recurrence-free prostate cancer survivors.

    Four hundred and sixteen recurrence-free prostate cancer survivors who were >1 year post-radiotherapy or radical prostatectomy were surveyed.

    Published February 18, 2020
  • Long-term toxicity of cisplatin in germ-cell tumor survivors.

    Testicular germ-cell tumors (GCT) are highly curable. A multidisciplinary approach, including cisplatin-based chemotherapy has resulted in cure in the majority of patients with GCT. Thus, the life expectancy of survivors will extend to many decades post-diagnosis.

    Published February 11, 2020
  • Long-Term Toxicity of Cisplatin in Germ-Cell Tumor Survivors.

    Testicular germ cell tumors (GCT) are highly curable. A multidisciplinary approach, including cisplatin-based chemotherapy has resulted in cure in the majority of patients with GCT. Thus, the life expectancy of survivors will extend to many decades post diagnosis.

    Published October 22, 2017